These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20462409)

  • 1. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
    Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
    BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss during progression of follicular lymphoma.
    Takeuchi S; de Vos S; Takeuchi N; Fermin AC; Grogan TM; Seo H; Said JW; Koeffler HP
    Leuk Res; 2004 Jun; 28(6):567-9. PubMed ID: 15120932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis in aggressive NHL.
    Chan WC; Huang JZ
    Ann Hematol; 2001; 80 Suppl 3():B38-41. PubMed ID: 11757704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis.
    Ross CW; Ouillette PD; Saddler CM; Shedden KA; Malek SN
    Clin Cancer Res; 2007 Aug; 13(16):4777-85. PubMed ID: 17699855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.
    Herold T; Mulaw MA; Jurinovic V; Seiler T; Metzeler KH; Dufour A; Schneider S; Kakadia PM; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Dreyling M; Bohlander SK
    Leuk Lymphoma; 2013 Aug; 54(8):1652-7. PubMed ID: 23189934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
    Scholtysik R; Kreuz M; Hummel M; Rosolowski M; Szczepanowski M; Klapper W; Loeffler M; Trümper L; Siebert R; Küppers R;
    Int J Cancer; 2015 Mar; 136(5):1033-42. PubMed ID: 25042405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
    Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H
    Blood; 2007 Feb; 109(3):1202-10. PubMed ID: 17053054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.
    Sebastián E; Alcoceba M; Martín-García D; Blanco Ó; Sanchez-Barba M; Balanzategui A; Marín L; Montes-Moreno S; González-Barca E; Pardal E; Jiménez C; García-Álvarez M; Clot G; Carracedo Á; Gutiérrez NC; Sarasquete ME; Chillón C; Corral R; Prieto-Conde MI; Caballero MD; Salaverria I; García-Sanz R; González M
    Ann Hematol; 2016 Jan; 95(2):253-62. PubMed ID: 26573278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma.
    Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H
    Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22-q34 in non-Hodgkin's lymphomas.
    Meléndez B; Cuadros M; Robledo M; Rivas C; Fernández-Piqueras J; Martínez-Delgado B; Benítez J
    Leuk Res; 2003 Jul; 27(7):627-33. PubMed ID: 12681362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
    Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
    BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
    Argos M; Kibriya MG; Jasmine F; Olopade OI; Su T; Hibshoosh H; Ahsan H
    Cancer Genet Cytogenet; 2008 Apr; 182(2):69-74. PubMed ID: 18406867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
    Beroukhim R; Lin M; Park Y; Hao K; Zhao X; Garraway LA; Fox EA; Hochberg EP; Mellinghoff IK; Hofer MD; Descazeaud A; Rubin MA; Meyerson M; Wong WH; Sellers WR; Li C
    PLoS Comput Biol; 2006 May; 2(5):e41. PubMed ID: 16699594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Pei J; Robu V; Feder M; Cheung M; Neumann-Domer E; Talarchek J; Dulaimi E; Millenson MM; Testa JR
    Cancer Genet; 2014 Mar; 207(3):98-102. PubMed ID: 24704113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.